Company intelligence

Isomorphic Labs

As of November 17, 2026, Isomorphic Labs has raised at least $7.7B in equity across 3 sourced funding rounds.

Isomorphic Labs at a glance

As of
Equity raised
$7.7B[1]
Across 3 sourced roundsDerived
Lead investors
Greenoaks, Sequoia Capital, Thrive Capital[2]
Across 3 sourced rounds
  1. [1] Equity raised: Sum of the 3 sourced equity rounds in the funding history below (debt, tender offers and rumored rounds excluded), November 17, 2026
  2. [2] Lead investors: TechCrunch, November 17, 2026

Is something wrong on this page?

Recent changes

  1. Nov 17, 2026Raised $5B Series C TechCrunch
  2. Nov 17, 2026New investor: Andreessen Horowitz TechCrunch
  3. Nov 17, 2026New investor: Sequoia Capital TechCrunch
  4. Nov 17, 2026New investor: Greenoaks TechCrunch
  5. Nov 17, 2026Isomorphic Labs Raises $5B Series C | 2.4x Its $2.1B May Round Pulse story
Earlier changes (10)
  1. Nov 4, 2026Reportedly raised ~$5B at a ~$50B valuationRumored The Next Web (citing Bloomberg)
  2. Nov 4, 2026First reported valuation: ~$50BRumored The Next Web (citing Bloomberg)
  3. May 12, 2026Raised $2.1B Series B Tech.eu
  4. May 12, 2026New investor: Temasek Tech.eu
  5. May 12, 2026New investor: MGX Tech.eu
  6. May 12, 2026New investor: CapitalG Tech.eu
  7. Mar 31, 2025Raised $600M Isomorphic Labs
  8. Mar 31, 2025New investor: Thrive Capital Isomorphic Labs
  9. Mar 31, 2025New investor: Alphabet Isomorphic Labs
  10. Mar 31, 2025New investor: Google Ventures (GV) Isomorphic Labs

Funding history

4 equity events Β· newest first Β· sources dated per row
DateRoundAmountValuationLead investorsSource
Nov 17, 2026Series C$5Bβ€”
GreenoaksunverifiedSequoia Capitalunverified
WithAndreessen HorowitzunverifiedGoogle Ventures (GV)unverifiedCapitalGunverifiedThrive CapitalunverifiedMGXunverifiedTemasekunverifiedUK Sovereign AI Fund
TechCrunch
Nov 4, 2026Funding roundRumorednot counted: rumored~$5B~$50Bpost-money
β€”
The Next Web (citing Bloomberg)
May 12, 2026Series B$2.1Bβ€”
Thrive Capitalunverified
WithAlphabetunverifiedGoogle Ventures (GV)unverifiedMGXunverifiedTemasekunverifiedCapitalGunverifiedUK Sovereign AI Fund
Tech.eu
Mar 31, 2025Funding round$600Mβ€”
Thrive Capitalunverified
WithGoogle Ventures (GV)unverifiedAlphabetunverified
Isomorphic Labs

Equity only. β€œEquity raised” above sums the rounds with a dated, linked source; rumored rounds, tender offers and secondary sales are listed but not counted, and debt financing is listed separately.

Funding timeline Β· 4 rounds Β· $13B tracked
$0.0M$2.8B$5.6B$600MRoundMar 25$2.1BSeries BMay 26$5.0BRoundNov 26$5.0BSeries CNov 26
Cumulative equity raised (sourced rounds)
$0M$4.2B$8.5B2025-032026-052026-11
Underlying values
As ofValueMethodSource
Nov 17, 2026$7.7BDerivedTechCrunch
May 12, 2026$2.7BDerivedTech.eu
Mar 31, 2025$600MDerivedIsomorphic Labs

Investors

Latest Pulse

  1. Isomorphic Labs Raises $5B Series C | 2.4x Its $2.1B May RoundIsomorphic Labs raised a $5 billion Series C co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz joining, to push its AI-designed drug candidates toward clinical trials; the company did not disclose its valuation.β†’
  2. Genesis AI Hits $3.5B With $500M Series A | Nvidia, AMD Back Eno RobotGenesis AI raised a $500 million Series A at a $3.5 billion post-money valuation, co-led by Premji Invest, Khosla Ventures and Eclipse, to build more of its Eno general-purpose robot for factories, warehouses and labs.β†’
  3. Yosemite Closes $350M Fund II For Reed Jobs's Cancer BetsReed Jobs's venture firm Yosemite closed its second fund at $350 million, up from a $200 million first close in January, to back startups and research aimed at making cancer non-lethal.β†’
  4. Pathos AI Hits $3B Valuation In $237M Round Led By BMSPathos AI raised $237 million in a Series E led by Bristol Myers Squibb at a $3 billion valuation, as Big Pharma deepens its direct bet on AI-designed cancer drugs.β†’
  5. Warp Sciences Raises $215M To Automate Drug-Discovery LabsKevin Weil, a former OpenAI science lead, has raised $215 million at an $865 million valuation for Warp Sciences, which trains robots to automate lab work for drug discovery.β†’
  6. OpenAI Acquires AI Biotech Startup Orchestra BioOpenAI acquired four-year-old AI biotech startup Orchestra Bio, whose agents handle operational work in drug discovery, folding its team into OpenAI's Rosalind life-sciences platform; deal terms were not disclosed.β†’
  7. Biohub, Google, Meta And DOE Back $1.8B Virtual Cell BetChan Zuckerberg Biohub is joining Google DeepMind, Meta, Isomorphic Labs, the Department of Energy and the NIH on a roughly $1.8 billion push to build an AI model of a living human cell.β†’
  8. Why AI Deals Are Repricing In Months, Not YearsFour venture-backed companies repriced at two to five times their own prior valuation marks in six weeks, and only one of them trains foundation models -- evidence investors are underwriting growth speed broadly, not just an AI-label premium.β†’
  9. Anthropic's Claude Finds A New CRISPR-Like SystemAnthropic says its Claude model autonomously identified a novel enzyme system in bacteriophage DNA that could function as a new gene-editing mechanism, discovered inside the company's new AI biology lab.β†’
  10. Enveda Biosciences Raises $311M Series E At $2BBoulder-based Enveda Biosciences raised a $311 million Series E led by Catalio Capital Management at roughly a $2 billion valuation, funding its AI platform that mines natural compounds for new drug candidates.β†’

Coverage Timeline

newest first
  1. Nov 17, 2026FUNDINGIsomorphic Labs Raises $5B Series C | 2.4x Its $2.1B May Round$5B Series C→

All Coverage

Value Add Research

Related Companies

Isomorphic Labs FAQ

How much has Isomorphic Labs raised?

Isomorphic Labs has raised at least $7.7B in equity across 3 sourced funding rounds tracked by Value Add VC. The most recent was a $5B Series C in November 2026, reported by TechCrunch. Debt financing, tender offers and secondary sales are not counted.

Who invested in Isomorphic Labs?

Lead investors in Isomorphic Labs's sourced funding rounds include Greenoaks, Sequoia Capital and Thrive Capital. Per round: its November 2026 Series C was led by Greenoaks and Sequoia Capital; its May 2026 Series B was led by Thrive Capital; its March 2025 funding round was led by Thrive Capital.

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data Β·